rSap2p

N/A

Report date: 2025/03/19 20:00:56

Base Information

Drug NamerSap2p
Drug Alias Nametherapeutic vaccine (Los Angeles BioMedical Research Institute at Harbor-UCLA Medical Center)
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsCandidiasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryEurope
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of California, Los Angeles
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of California, Los Angeles
Inactive CompaniesN/A
Active IndicationsCandidiasis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A